J Rhinol.  2015 Nov;22(2):89-95. 10.18787/jr.2015.22.2.89.

Predictors of Adherence with Positive Airway Pressure Treatment in Patients with Obstructive Sleep Apnea in Korean

• Kim MJ
• Kim MJ
• Bae SH
• Park CH
• Kim DK

• KMID: 2223203
• DOI: http://doi.org/10.18787/jr.2015.22.2.89

Abstract

BACKGROUND AND OBJECTIVES
Application of automatic positive airway pressure (APAP) is regarded as the primary therapy for patients with obstructive sleep apnea syndrome (OSAS). However, a low adherence rate is a major problem with APAP treatment in OSAS patients. Therefore, the aim of the present study is to assess factors related to good adherence of APAP therapy in OSAS Korean patients. MATERIALS AND METHOD: Of 112 consecutive newly diagnosed moderate to severe OSAS patients, 70 were enrolled in this study. All patients received APAP therapy for 2 weeks, along with reinforcing intervention, consisting of motivational reinforcement and technical support. All APAP therapy involved a device rental service. After 2 weeks of treatment, patients had to choose the kind of treatment for OSAS [APAP therapy (good adherence) or alternative treatment options (poor adherence)].
RESULTS
After 6 months, the adherence rate to APAP therapy was 35.7% (n=25). No statistically significant difference was observed between the good and poor adherence groups with regard to snoring intensity, apnea-hypopnea index, and mean O2 saturation after adjusting for age, sex, body mass index, marital status, and socioeconomic status. However, we found that excessive daytime sleepiness and lowest O2 saturation were significantly associated with good adherence [adjusted odds ratios (ORs)=9.515 and 2.327] after adjusting for age, sex, body mass index, marital status, and socioeconomic status.
CONCLUSION
Our findings suggest that excessive daytime sleepiness and lowest O2 saturation are important factors to identify good adherence to APAP treatment in Korean OSAS patients.

Keyword

Obstructive sleep apnea syndrome; Automatic positive airway pressure; Adherence

MeSH Terms

Acetaminophen
Body Mass Index
Humans
Marital Status
Odds Ratio
Sleep Apnea, Obstructive*
Snoring
Social Class
Acetaminophen

Reference

References

1). Jung JH, Kim SY, Yoon BK, Kang IG, Kim ST, Park KH. The Consequence of Cardiovascular Sympathetic Nervous System in Obstructive Sleep Apnea. Korean J Otorhinolaryngol-Head Neck Surg. 2008; 51(11):1020–4.

2). Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med. 1993; 328(17):1230–5.

3). Kim JH, Chung TS, Kim NH, Seong SY, Lee GB, Kim KS. Relationship between Upper Airway Computed Tomography in the Awake State and Polysomnograpy in Obstructive Sleep Apnea Patients. J Rhinol. 2011; 18(1):20–8.

4). Sankri-Tarbichi AG. Obstructive sleep apnea-hypopnea syndrome: Etiology and diagnosis. Avicenna J Med. 2012; 2(1):3–8.

5). Epstein LJ, Kristo D, Strollo PJ Jr, Friedman N, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and longterm care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009; 5(3):263–6.

6). Hoffstein V. Review of oral appliances for treatment of sleep-dis-ordered breathing. Sleep Breath. 2007; 11(1):1–22.

7). Ballester E, Badia JR, Hernández L, Carrasco E, de Pablo J, For-nas C, et al. Evidence of the effectiveness of continuous positive airway pressure in the treatment of sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 1999 (5 pt 1);159:. 495–501.

8). Kim TH, Yun HJ, Myung NS, Koo SK. The Outcome of Uvulopalatal Flap in Obstructive Sleep Apnea Syndrome Patients. J Rhinol. 2007; 14(1):36–9.

9). Smith SS, Lang CP, Sullivan KA, War ren J. A preliminary investigation of the effectiveness of a sleep apnea education program. J Psychosom Res. 2004; 56(2):245–9.

10). Han EK, Yoon IY, Chung S. The compliance and effect of CPAP in Obstructive Sleep Apnea Syndrome. Sleep Med Psychophysiol. 2006; 13(2):52–8.

11). Choi JB, Lee SH, Jeong DU. Compliance of nasal continuous positive airway pressure in patients with obstructive sleep apnea syndrome. Sleep Med Psychophysiol. 2006; 13(1):27–32.

12). Sin DD, Mayers I, Man GC, Pawluk L. Long-term compliance rates to continuous positive airway pressure in obstructive sleep apnea: a population-based study. Chest. 2002; 12(2):430–5.

13). Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. Am Rev Respir Dis. 1993; 147(4):887–95.

14). Kim HY, Jang MS. Improving Compliance for Continuous Positive Airway Pressure Compliance and Possible Influencing Factors. Korean J Otorhinolaryngol-Head Neck Surg. 2014; 57(1):7–14.

15). Lutfey KE, Wishner WJ. Beyond ‘compliance' is ‘adherence': improving the prospect of diabetes care. Diab Care. 1999; 22(4):635–9.

16). Shapiro GK, Shapiro CM. Factors that influence CPAP adherence: an overview. Sleep Breath. 2010; 14(4):323–35.

17). Ahmed O, Parthasarathy S. APAP and Alternative Titration Methods. Sleep Med Clin. 2010; 5(3):361–8.

18). Loube DI, Gay PC, Strohl KP, Pack AI, White DP, Collop NA. Indications for positive airway pressure treatment of adult obstructive sleep apnea patients: A consensus statement. Chest. 1999; 115(3):863–6.

19). Wild MR, Engleman HM, Douglas NJ, Espie CA. Can psychological factors help us to determine adherence to CPAP? A prospective study. Eur Respir J. 2004; 24(3):461–5.

20). Aloia MS, Stanchina M, Arnedt JT, Malhotra A, Millman RP. Treatment adherence and outcomes in flexible vs standard continuous positive airway pressure therapy. Chest. 2005; 127(6):2085–93.

21). Villar I, Izuel M, Carrizo S, Vicente E, Marin JM. Medication adherence and persistence in severe obstructive sleep apnea. Sleep. 2009; 32(5):623–8.

22). Budhiraja R, Parthasarathy S, Drake CL, Roth T, Sharief I, Budhiraja P, et al. Early CPAP use identifies subsequent adherence to CPAP therapy. Sleep. 2007; 30(3):320–4.

23). Wang JH, Kim YR, Jang YJ, Lee BJ, Chung YS. Compliance of Au-to-adjusting Positive Airway Pressure in Korean Obstructive Sleep Apnea Patients. J Rhinol. 2006; 13(2):92–6.

24). Weaver TE, Maislin G, Dinges DF, Bloxham T, George CF, Greenberg H, et al. Relationship between hours of CPAP use and achieving normal levels of sleepiness and daily functioning. Sleep. 2007; 30(6):711–9.

25). Yetkin O, Kunter E, Gunen H. CPAP compliance in patients with obstructive sleep apnea syndrome. Sleep Breath. 2008; 12(4):365–7.

26). Krieger J, Kurtz D, Petiau C, Sforza E, Trautmann D. Long-term compliance with CPAP therapy in obstructive sleep apnea patients and in snorers. Sleep. 1996; 19(9 Suppl):S136–43.

27). Joo MJ, Herdegen JJ. Sleep apnea in an urban public hospital: assessment of severity and treatment adherence. J Clin Sleep Med. 2007; 3(3):285–8.

28). Gay P, Weaver T, Loube D, Iber C. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Sleep. 2006; 29(3):381–401.

29). Engleman HM, Martin SE, Douglas NJ. Compliance with CPAP therapy in patients with the sleep apnoea/hypopnea syndrome. Thorax. 1994; 49:263–266.

30). Wells RD, Freedland KE, Carney RM, Duntley SP, Stepanski EJ. Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosom Med. 2007; 69(5):449–54.

31). Meslier N, Lebrun T, Grillier-Lanoir V, Rolland N, Henderick C, Sailly JC, et al. A French survey of 3,225 patients treated with CPAP for obstructive sleep apnoea: benefits, tolerance, compliance and quality of life. Eur Respir J. 1998; 12(1):185–92.

32). Thompson SC, Nanni C, Schwankovsky L. Patient-oriented interventions to improve communication in a medical office visit. Health Psychol. 1990; 9(4):390–404.

33). van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J, et al. Furthering patient adherence: a position paper of the international expert forum on patient adherence based on an internet forum discussion. BMC Health Serv Res. 2008; 8:47.

34). Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest. 2003; 124(3):942–7.

35). Brin YS, Reuveni H, Greenberg S, Tal A, Tarasiuk A. Determinants affecting initiation of continuous positive airway pressure treatment. Isr Med Assoc J. 2005; 7(1):13–8.

36). Kim JH, Kwon MS, Song HM, Lee BJ. Compliance with Positive Airway Pressure Treatment for Obstructive Sleep Apnea. Clinical and Experimental Otorhinolaryngology. 2009; 2(2):90–6.